StonvexLoading…
StonvexStonvexStonvexCore line items from ALG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $441.84M | $417.15M | $1.60B | $1.23B | $810.02M |
Operating Income | Not available | $42.16M | $151.61M | $129.08M | $91.54M |
Net Income | Not available | $29.18M | $103.80M | $88.29M | $62.91M |
EPS (Diluted) | $2.77 | $2.41 | $8.59 | $7.31 | $5.21 |
Total Assets | Not available | $1.73B | $1.61B | $1.59B | $1.56B |
Total Liabilities | Not available | $554.52M | $457.91M | $462.37M | $442.25M |
Cash & Equivalents | Not available | $195.23M | $309.66M | $244.81M | $201.82M |
Free Cash Flow OCF − CapEx | Not available | $-28.02M | $146.92M | $77.02M | $23.94M |
Shares Outstanding | Not available | 12.10M | 12.07M | 12.07M | 12.06M |